{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T22:20:07Z","timestamp":1782512407762,"version":"3.54.5"},"reference-count":51,"publisher":"SAGE Publications","issue":"1","license":[{"start":{"date-parts":[[2019,2,5]],"date-time":"2019-02-05T00:00:00Z","timestamp":1549324800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JPD"],"published-print":{"date-parts":[[2019,2,5]]},"DOI":"10.3233\/jpd-181443","type":"journal-article","created":{"date-parts":[[2019,2,5]],"date-time":"2019-02-05T11:40:20Z","timestamp":1549366820000},"page":"97-107","source":"Crossref","is-referenced-by-count":25,"title":["HSP90 and Its Novel Co-Chaperones, SGT1 and CHP-1, in Brain of Patients with Parkinson\u2019s Disease and Dementia with Lewy Bodies"],"prefix":"10.1177","volume":"9","author":[{"given":"Anastasiia","family":"Bohush","sequence":"first","affiliation":[{"name":"Nencki Institute of Experimental Biology, Polish Academy of Sciences, Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gra\u017cyna","family":"Niewiadomska","sequence":"additional","affiliation":[{"name":"Nencki Institute of Experimental Biology, Polish Academy of Sciences, Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serge","family":"Weis","sequence":"additional","affiliation":[{"name":"Division of Neuropathology, Neuromed Campus, Kepler University Hospital, Johannes Kepler University, Linz, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Filipek","sequence":"additional","affiliation":[{"name":"Nencki Institute of Experimental Biology, Polish Academy of Sciences, Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","reference":[{"key":"10.3233\/JPD-181443_ref1","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.3892\/mmr.2014.3011","article-title":"Proteasome inhibitor-induced autophagy in PC12 cells overexpressing A53T mutant \u03b1-synuclein","volume":"11","author":"Lan","year":"2015","journal-title":"Mol Med Rep"},{"key":"10.3233\/JPD-181443_ref2","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.parkreldis.2006.12.014","article-title":"Non-motor dysfunction in Parkinson\u2019s disease","volume":"13","author":"Ziemssen","year":"2007","journal-title":"Parkinsonism Relat Disord"},{"key":"10.3233\/JPD-181443_ref3","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.bbr.2009.12.048","article-title":"The cholinergic system and Parkinson disease","volume":"221","author":"Bohnen","year":"2011","journal-title":"Behav Brain Res"},{"key":"10.3233\/JPD-181443_ref4","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/nrn.2017.25","article-title":"The two-century journey of Parkinson disease research","volume":"18","author":"Przedborski","year":"2017","journal-title":"Nat Rev Neurosci"},{"key":"10.3233\/JPD-181443_ref5","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/nrn.2016.178","article-title":"Selective neuronal vulnerability in Parkinson disease","volume":"18","author":"Surmeier","year":"2017","journal-title":"Nat Rev Neurosci"},{"key":"10.3233\/JPD-181443_ref6","doi-asserted-by":"crossref","first-page":"17013","DOI":"10.1038\/nrdp.2017.13","article-title":"Parkinson disease","volume":"3","author":"Poewe","year":"2017","journal-title":"Nat Rev Dis Primers"},{"issue":"Suppl 1","key":"10.3233\/JPD-181443_ref7","doi-asserted-by":"crossref","first-page":"S30","DOI":"10.1016\/j.parkreldis.2017.07.033","article-title":"Neuropathology of Parkinson disease","volume":"46","author":"Dickson","year":"2018","journal-title":"Relat Disord"},{"key":"10.3233\/JPD-181443_ref8","doi-asserted-by":"crossref","first-page":"109","DOI":"10.3389\/fnagi.2018.00109","article-title":"Cellular and molecular basis of neurodegeneration in Parkinson disease","volume":"10","author":"Zeng","year":"2018","journal-title":"Front Aging Neurosci"},{"key":"10.3233\/JPD-181443_ref9","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1159\/000072807","article-title":"Systematic review and meta-analysis show that dementia with Lewy bodies is a visual-perceptual and attentional-executive dementia","volume":"16","author":"Collerton","year":"2003","journal-title":"Dement Geriatr Cogn Disord"},{"key":"10.3233\/JPD-181443_ref10","first-page":"442","article-title":"Clinical and cognitive phenotype of mild cognitive impairment evolving to dementia with Lewy dodies","volume":"5","author":"Cagnin","year":"2015","journal-title":"Extra"},{"key":"10.3233\/JPD-181443_ref11","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s13195-017-0242-1","article-title":"Cognitive profile in prodromal dementia with Lewy bodies","volume":"9","author":"Kemp","year":"2017","journal-title":"Alzheimers Res Ther"},{"key":"10.3233\/JPD-181443_ref12","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1136\/jnnp.2005.081711","article-title":"Motor subtype and cognitive decline in Parkinson\u2019s disease, Parkinson\u2019s disease with dementia, and dementia with Lewy bodies","volume":"77","author":"Burn","year":"2006","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.3233\/JPD-181443_ref13","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1212\/WNL.47.5.1113","article-title":"Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): Report of the consortium on DLB International Workshop","volume":"47","author":"McKeith","year":"1996","journal-title":"Neurology"},{"key":"10.3233\/JPD-181443_ref14","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1126\/science.286.5446.1888","article-title":"Posttranslational quality control: Folding, refolding, and degrading proteins","volume":"286","author":"Wickner","year":"1999","journal-title":"Science"},{"key":"10.3233\/JPD-181443_ref15","doi-asserted-by":"crossref","first-page":"254","DOI":"10.3389\/fnins.2017.00254","article-title":"The Hsp70\/Hsp90 chaperone machinery in neurodegenerative diseases","volume":"11","author":"Lackie","year":"2017","journal-title":"Front Neurosci"},{"key":"10.3233\/JPD-181443_ref16","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1111\/bpa.12511","article-title":"Transcriptional network analysis in frontal cortex in Lewy body diseases with focus on dementia with Lewy bodies","volume":"28","author":"Santpere","year":"2018","journal-title":"Brain Pathol"},{"key":"10.3233\/JPD-181443_ref17","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1007\/PL00012491","article-title":"Heat-shock protein 90, a chaperone for folding and regulation","volume":"59","author":"Picard","year":"2002","journal-title":"Cell Mol Life Sci"},{"key":"10.3233\/JPD-181443_ref18","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.cell.2007.07.036","article-title":"Diverse cellular functions of the Hsp90 molecular chaperone uncovered using systems approaches","volume":"131","author":"McClellan","year":"2007","journal-title":"Cell"},{"key":"10.3233\/JPD-181443_ref19","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/nrm.2017.20","article-title":"The HSP90 chaperone machinery","volume":"18","author":"Schopf","year":"2017","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.3233\/JPD-181443_ref20","doi-asserted-by":"crossref","first-page":"947","DOI":"10.2353\/ajpath.2006.050770","article-title":"Convergence of heat shock protein 90 with ubiquitin in filamentous alpha-synuclein inclusions of alpha-synucleinopathies","volume":"168","author":"Uryu","year":"2006","journal-title":"Am J Pathol"},{"key":"10.3233\/JPD-181443_ref21","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S1097-2765(00)80184-7","article-title":"SGT1 encodes an essential component of the yeast kinetochore assembly pathway and a novel subunit of the SCF ubiquitin ligase complex","volume":"4","author":"Kitagawa","year":"1999","journal-title":"Mol Cell"},{"key":"10.3233\/JPD-181443_ref22","doi-asserted-by":"crossref","first-page":"161","DOI":"10.55782\/ane-2005-1549","article-title":"The expression and function of Sgt1 protein in eukaryotic cells","volume":"65","author":"Spiechowicz","year":"2005","journal-title":"Neurobiol Exp"},{"key":"10.3233\/JPD-181443_ref23","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1002\/(SICI)1521-1878(199911)21:11<932::AID-BIES5>3.0.CO;2-N","article-title":"The tetratricopeptide repeat: A Structural motif mediating protein-protein interactions","volume":"21","author":"Blatch","year":"1999","journal-title":"Bioessays"},{"key":"10.3233\/JPD-181443_ref24","doi-asserted-by":"crossref","first-page":"11777","DOI":"10.1073\/pnas.2033934100","article-title":"HSP90 interacts with RAR1 and SGT1 and is essential for RPS2-mediated disease resistance in Arabidopsis","volume":"100","author":"Takahashi","year":"2003","journal-title":"Proc Nat Acad Sci U S A"},{"key":"10.3233\/JPD-181443_ref25","doi-asserted-by":"crossref","first-page":"16511","DOI":"10.1074\/jbc.M400215200","article-title":"Human Sgt1 binds HSP90 through the CHORD-Sgt1 domain and not the tetratricopeptide repeat domain","volume":"279","author":"Lee","year":"2004","journal-title":"J Biol Chem"},{"key":"10.3233\/JPD-181443_ref26","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1016\/j.bbrc.2007.04.073","article-title":"Hsp70 is a new target of Sgt1\u2014an interaction modulated by S100A6","volume":"357","author":"Spiechowicz","year":"2007","journal-title":"Biochem Biophys Res Commun"},{"key":"10.3233\/JPD-181443_ref27","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.bbrc.2008.03.055","article-title":"Sgt1 has co-chaperone properties and is up-regulated by heat shock","volume":"370","author":"Zabka","year":"2008","journal-title":"Biochem Biophys Res Commun"},{"key":"10.3233\/JPD-181443_ref28","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.neuint.2006.03.009","article-title":"Density of Sgt1-immunopositive neurons is decreased in the cerebral cortex of Alzheimer\u2019s disease brain","volume":"49","author":"Spiechowicz","year":"2006","journal-title":"Neurochem Int"},{"key":"10.3233\/JPD-181443_ref29","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0014-5793(03)00892-5","article-title":"Chp-1 and melusin, two CHORD containing proteins in vertebrates","volume":"551","author":"Brancaccio","year":"2003","journal-title":"FEBS Lett"},{"key":"10.3233\/JPD-181443_ref30","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.devcel.2009.12.020","article-title":"Morgana\/chp-1, a ROCK inhibitor involved in centrosome duplication and tumorigenesis","volume":"18","author":"Ferretti","year":"2010","journal-title":"Dev Cell"},{"key":"10.3233\/JPD-181443_ref31","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.febslet.2004.12.005","article-title":"Mammalian CHORD-containing protein 1 is a novel heat shock protein 90-interacting protein","volume":"579","author":"Wu","year":"2005","journal-title":"FEBS Lett"},{"key":"10.3233\/JPD-181443_ref32","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/j.bbamcr.2010.05.005","article-title":"Morgana\/CHP-1 is a novel chaperone able to protect cells from stress","volume":"1803","author":"Michowski","year":"2010","journal-title":"Biochim Biophys Acta"},{"key":"10.3233\/JPD-181443_ref33","doi-asserted-by":"crossref","first-page":"3678","DOI":"10.4161\/cc.10.21.18202","article-title":"Morgana and melusin: Two fairies chaeroning signal transduction","volume":"10","author":"Ferretti","year":"2011","journal-title":"Cell Cycle"},{"key":"10.3233\/JPD-181443_ref34","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/BF00308809","article-title":"Neuropathological stageing of Alzheimer-related changes","volume":"82","author":"Braak","year":"1991","journal-title":"Acta Neuropathol"},{"key":"10.3233\/JPD-181443_ref35","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1212\/WNL.41.4.479","article-title":"The Consortium to Establish a Registry for Alzheimer\u2019s Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer\u2019s disease","volume":"41","author":"Mirra","year":"1991","journal-title":"Neurology"},{"key":"10.3233\/JPD-181443_ref36","first-page":"132","article-title":"Making the diagnosis of Alzheimer\u2019s disease. A primer for practicing pathologists","volume":"117","author":"Mirra","year":"1993","journal-title":"Arch Pathol Lab Med"},{"key":"10.3233\/JPD-181443_ref37","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","article-title":"Staging of brain pathology related to sporadic Parkinson\u2019s disease","volume":"24","author":"Braak","year":"2003","journal-title":"Neurobiol Aging"},{"key":"10.3233\/JPD-181443_ref38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jalz.2011.10.007","article-title":"National Institute on Aging-Alzheimer\u2019s Association guidelines for the neuropathologic assessment of Alzheimer\u2019s disease","volume":"8","author":"Hyman","year":"2012","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JPD-181443_ref39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00401-011-0910-3","article-title":"National Institute on Aging-Alzheimer\u2019s Association guidelines for the neuropathologic assessment of Alzheimer\u2019s disease: A Practical approach","volume":"123","author":"Montine","year":"2012","journal-title":"Acta Neuropathol"},{"key":"10.3233\/JPD-181443_ref40","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1212\/WNL.0000000000004058","article-title":"Diagnosis and management of dementia with Lewy bodies: Fourth Consensus Report of the DLB Consortium","volume":"89","author":"McKeith","year":"2017","journal-title":"Neurology"},{"key":"10.3233\/JPD-181443_ref41","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1046\/j.1365-2990.1998.00115.x","article-title":"Simplified neuropathological diagnosis of dementia with Lewy bodies","volume":"24","author":"Harding","year":"1988","journal-title":"Neuropathol Appl Neurobiol"},{"key":"10.3233\/JPD-181443_ref42","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1212\/WNL.54.10.1916","article-title":"Alpha synuclein cortical Lewy bodies correlate with dementia in Parkinson\u2019s disease","volume":"54","author":"Hurtig","year":"2000","journal-title":"Neurology"},{"key":"10.3233\/JPD-181443_ref43","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1038\/227680a0","article-title":"Cleavage of structural proteins during the assembly of the head of bacteriophage T4","volume":"227","author":"Laemmli","year":"1970","journal-title":"Nature"},{"key":"10.3233\/JPD-181443_ref44","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1046\/j.1471-4159.2002.01190.x","article-title":"Torsin A and heat shock proteins act as molecular chaperones: Suppression of alpha-synuclein aggregation","volume":"83","author":"McLean","year":"2002","journal-title":"J Neurochem"},{"key":"10.3233\/JPD-181443_ref45","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/j.1750-3639.2007.00048.x","article-title":"Proteomic identification of novel proteins in cortical Lewy bodies","volume":"17","author":"Leverenz","year":"2007","journal-title":"Brain Pathol"},{"key":"10.3233\/JPD-181443_ref46","doi-asserted-by":"crossref","first-page":"31190","DOI":"10.1074\/jbc.M109.057240","article-title":"The molecular chaperone Hsp90 modulates intermediate steps of amyloid assembly of the Parkinson-related protein alpha-synuclein","volume":"284","author":"Falsone","year":"2009","journal-title":"J Biol Chem"},{"key":"10.3233\/JPD-181443_ref47","doi-asserted-by":"crossref","first-page":"4614","DOI":"10.1016\/j.jmb.2013.08.006","article-title":"Hsp90 inhibits alpha-synuclein aggregation by interacting with soluble oligomers","volume":"425","author":"Daturpalli","year":"2013","journal-title":"J Mol Biol"},{"key":"10.3233\/JPD-181443_ref48","doi-asserted-by":"crossref","first-page":"3784","DOI":"10.1093\/hmg\/ddn276","article-title":"Novel suppressors of alpha-synuclein toxicity identified using yeast","volume":"17","author":"Liang","year":"2008","journal-title":"Hum Mol Genet"},{"key":"10.3233\/JPD-181443_ref49","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1124\/jpet.109.158436","article-title":"Brain-permeable small-molecule inhibitors of Hsp90 prevent alpha-synuclein oligomer formation and rescue alpha-synuclein-induced toxicity","volume":"332","author":"Putcha","year":"2010","journal-title":"J Pharmacol Exp Ther"},{"key":"10.3233\/JPD-181443_ref50","doi-asserted-by":"crossref","first-page":"724","DOI":"10.3390\/ijms10030724","article-title":"Molecular pathology of Lewy body diseases","volume":"10","author":"Beyer","year":"2009","journal-title":"Int J Mol Sci"},{"key":"10.3233\/JPD-181443_ref51","first-page":"1223","article-title":"Dementia with Lewy bodies: An Emerging disease","volume":"73","author":"Neef","year":"2006","journal-title":"Am Fam Physician"}],"container-title":["Journal of Parkinson's Disease"],"original-title":[],"link":[{"URL":"https:\/\/content.iospress.com\/download?id=10.3233\/JPD-181443","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T04:46:24Z","timestamp":1777610784000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.3233\/JPD-181443"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,5]]},"references-count":51,"journal-issue":{"issue":"1"},"URL":"https:\/\/doi.org\/10.3233\/jpd-181443","relation":{},"ISSN":["1877-7171","1877-718X"],"issn-type":[{"value":"1877-7171","type":"print"},{"value":"1877-718X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,5]]}}}